Published in Pharma Law Weekly, October 21st, 2008
"Furthermore, p53 is one of the most important negative regulators of the pro-inflammatory transcription factor nuclear factor kappa b (NF kappa B). In this respect the investigation of polymorphisnis in the p53-network could be a promising approach contributing susceptibility of WG and its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly